Nomograms have been widely used in various malignant tumors.[24-26] Kattan et al. [27] constructed a nomogram that included pretreatment serum prostate-specific antigen levels, biopsy Gleason scores and clinical stages and found that it could predict the 5-year treatment failure probability of clinically localized prostate cancer patients who underwent radical prostatectomy. The gene discussed is KLK3; the disease is prostate cancer.